Lol. People get way too enthusiastic. There's a lot to be excited about, and Anavex may be on the verge of something big. But, getting past regulatory hurdles is going to take a long time and require a lot of investor patience.
It's going to be even more difficult for the latter as the stock continues its slide back into the 2s. Lots of investors might give up on this one now that trials aren't happening in 2017, and move on to something else. Which is exactly what the shorts are hoping for.